metyrapone has been researched along with Adenoma, Basal Cell in 86 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Excerpt | Relevance | Reference |
---|---|---|
"18 patients were studied on 21 occasions: three with Cushing's disease without metyrapone treatment prior to IPSS (M-), 11 with Cushing's disease with metyrapone pretreatment (M+), three with ectopic ACTH syndrome, and one with pseudo-Cushing's syndrome." | 7.69 | Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. ( Atkinson, RL; Cameron, DP; Cuneo, RC; Harper, J; Lee, W; Mitchell, K; Salkield, I; Ward, G, 1997) |
"To analyse the clinical and biochemical effects of metyrapone in the treatment of Cushing's syndrome." | 7.68 | Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. ( Besser, GM; Grossman, AB; Howlett, TA; Perry, L; Rees, LH; Trainer, PJ; Verhelst, JA; Wass, JA, 1991) |
"A diagnosis of preclinical Cushing's disease was made, and she was treated with 11-hydroxylase inhibitor metyrapone." | 5.34 | Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy. ( Nomura, K; Ohmori, K; Ohmori, N; Takano, K, 2007) |
"Hypercortisolism was successfully controlled with metyrapone, which was started at 8 weeks of gestation." | 5.33 | Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. ( Blanco, C; Maqueda, E; Rodriguez, A; Rubio, JA, 2006) |
"Aldosterone excretion was high, normal, or low in each of the three types of Cushing's syndrome." | 5.26 | Deoxycorticosterone and aldosterone excretion in Cushing's syndrome. ( Cassar, J; Joplin, GF; Kelly, WF; Loizou, S; Mashiter, K, 1980) |
" by metyrapone test or by congenital adrenal hyperplasia resulting from 11 beta-hydroxylase deficiency." | 3.69 | An alternate pathway to androstenedione synthesis by human adrenals: evidence of a balance in 11 beta-hydroxylase and 17,20-lyase activities leading to androstenedione. ( Auzéby, A; Bogdan, A; Touitou, Y, 1995) |
"18 patients were studied on 21 occasions: three with Cushing's disease without metyrapone treatment prior to IPSS (M-), 11 with Cushing's disease with metyrapone pretreatment (M+), three with ectopic ACTH syndrome, and one with pseudo-Cushing's syndrome." | 3.69 | Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. ( Atkinson, RL; Cameron, DP; Cuneo, RC; Harper, J; Lee, W; Mitchell, K; Salkield, I; Ward, G, 1997) |
"To analyse the clinical and biochemical effects of metyrapone in the treatment of Cushing's syndrome." | 3.68 | Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. ( Besser, GM; Grossman, AB; Howlett, TA; Perry, L; Rees, LH; Trainer, PJ; Verhelst, JA; Wass, JA, 1991) |
" In congenital adrenal hyperplasia, plasma ACTH concentrations mirror, together with 17-alpha-hydroxyprogesterone, the extent of ACTH suppression." | 3.67 | Plasma ACTH in diagnosis and control of adrenal disorders. ( Baumann, JB; Eberle, AN; Girard, J, 1986) |
"Hypercortisolism induced by Cushing disease causes high morbidity and mortality." | 2.48 | New prospects for drug treatment in Cushing disease. ( Barahona Constanzo, MJ; del Pozo Picó, C, 2012) |
"Effective treatment of Cushing's disease can normalize biochemical levels, reverse comorbidities, and improve overall survival and quality of life." | 2.45 | Rationale for treatment and therapeutic options in Cushing's disease. ( Petersenn, S; Stewart, PM, 2009) |
"Since hypercortisolism due to active Cushing's disease may worsen a COVID-19 infection, multi-disciplinary management that includes appropriate and prompt treatment strategies is mandatory in such cases." | 1.62 | Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. ( Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A, 2021) |
"BLA = bilateral adrenalectomy CD = Cushing disease CS = Cushing syndrome eCRF = electronic case report form MRI = magnetic resonance imaging PCOS = polycystic ovary syndrome." | 1.46 | BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ( Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS, 2017) |
"The hypercortisolism is a rare endocrine disease characterized by an autonomous steroid secretion or excessive adrenal stimulation by ACTH." | 1.43 | [Indications and future perspectives in the pharmacological treatment of hypercortisolism]. ( Stigliano, A; Toscano, V, 2016) |
"A long-term recurrence rate of Cushing's disease ranging from 2%-25% has been reported." | 1.39 | [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease]. ( Abellán Galiana, P; Escrivá, CM; Fajardo Montañana, C; Gómez Vela, J; Lillo, VR; Riesgo Suárez, PA, 2013) |
"Because TS may cause pituitary insufficiency in some of these patients, early postoperative assessment of pituitary function is essential for appropriate endocrine management." | 1.38 | The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas. ( Biermasz, NR; Kokshoorn, NE; Pereira, AM; Rambach, AH; Roelfsema, F; Romijn, JA; Smit, JW, 2012) |
"A diagnosis of preclinical Cushing's disease was made, and she was treated with 11-hydroxylase inhibitor metyrapone." | 1.34 | Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy. ( Nomura, K; Ohmori, K; Ohmori, N; Takano, K, 2007) |
"Hypercortisolism was successfully controlled with metyrapone, which was started at 8 weeks of gestation." | 1.33 | Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. ( Blanco, C; Maqueda, E; Rodriguez, A; Rubio, JA, 2006) |
"In vitro perifusion of the pituitary adenoma obtained by surgery revealed that o-CRF also stimulated ACTH and beta-EP release in a dose-responsive manner (10(-9)M 10(-5)M) and that dopamine suppressed their basal secretion." | 1.27 | Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease. ( Fujita, T; Hirata, Y; Nakashima, H; Tomita, M; Uchihashi, M, 1985) |
"Aldosterone excretion was high, normal, or low in each of the three types of Cushing's syndrome." | 1.26 | Deoxycorticosterone and aldosterone excretion in Cushing's syndrome. ( Cassar, J; Joplin, GF; Kelly, WF; Loizou, S; Mashiter, K, 1980) |
"Treatment with metyrapone decreased her cortisol production and produced clinical remission of Cushing's syndrome." | 1.25 | The immunological hazard of Cushing's syndrome. ( Britton, S; Sjoberg, HE; Thorén, M, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 61 (70.93) | 18.7374 |
1990's | 8 (9.30) | 18.2507 |
2000's | 9 (10.47) | 29.6817 |
2010's | 6 (6.98) | 24.3611 |
2020's | 2 (2.33) | 2.80 |
Authors | Studies |
---|---|
Newell-Price, J | 1 |
Nieman, LK | 1 |
Reincke, M | 1 |
Tabarin, A | 1 |
Yuno, A | 1 |
Kenmotsu, Y | 1 |
Takahashi, Y | 1 |
Nomoto, H | 1 |
Kameda, H | 1 |
Cho, KY | 1 |
Nakamura, A | 1 |
Yamashita, Y | 1 |
Nakamura, J | 1 |
Nakakubo, S | 1 |
Kamada, K | 1 |
Suzuki, M | 1 |
Sugino, H | 1 |
Inoshita, N | 1 |
Konno, S | 1 |
Miyoshi, H | 1 |
Atsumi, T | 1 |
Sawamura, Y | 1 |
Shimatsu, A | 1 |
Geer, EB | 1 |
Shafiq, I | 1 |
Gordon, MB | 1 |
Bonert, V | 1 |
Ayala, A | 1 |
Swerdloff, RS | 1 |
Katznelson, L | 1 |
Lalazar, Y | 1 |
Manuylova, E | 1 |
Pulaski-Liebert, KJ | 1 |
Carmichael, JD | 1 |
Hannoush, Z | 1 |
Surampudi, V | 1 |
Broder, MS | 1 |
Cherepanov, D | 1 |
Eagan, M | 1 |
Lee, J | 1 |
Said, Q | 1 |
Neary, MP | 1 |
Biller, BMK | 1 |
Stigliano, A | 1 |
Toscano, V | 1 |
Stewart, PM | 1 |
Petersenn, S | 1 |
Schiemer, R | 1 |
Latibeaudiere, M | 1 |
Close, C | 1 |
Fox, R | 1 |
Kokshoorn, NE | 1 |
Romijn, JA | 1 |
Roelfsema, F | 1 |
Rambach, AH | 1 |
Smit, JW | 1 |
Biermasz, NR | 1 |
Pereira, AM | 1 |
Barahona Constanzo, MJ | 1 |
del Pozo Picó, C | 1 |
Abellán Galiana, P | 1 |
Fajardo Montañana, C | 1 |
Riesgo Suárez, PA | 1 |
Gómez Vela, J | 1 |
Escrivá, CM | 1 |
Lillo, VR | 1 |
Shaw, JA | 1 |
Pearson, DW | 1 |
Krukowski, ZH | 1 |
Fisher, PM | 1 |
Bevan, JS | 1 |
KAPLAN, NM | 2 |
JANSEN, W | 1 |
DOORENBOS, H | 1 |
BEKS, JW | 1 |
JENKINS, JS | 3 |
ELKINGTON, SG | 2 |
SOBOTA, JT | 1 |
REED, RJ | 1 |
MINDER, E | 1 |
MARKOFF, NG | 1 |
NEHER, R | 1 |
KAHNT, FW | 1 |
HOLMDAHL, TH | 1 |
DITZEL, J | 1 |
Miyoshi, T | 1 |
Otsuka, F | 1 |
Suzuki, J | 1 |
Inagaki, K | 1 |
Takeda, M | 1 |
Kano, Y | 1 |
Yamashita, T | 1 |
Ogura, T | 1 |
Date, I | 1 |
Tanaka, Y | 1 |
Hashimoto, K | 1 |
Makino, H | 1 |
Blanco, C | 1 |
Maqueda, E | 1 |
Rubio, JA | 1 |
Rodriguez, A | 1 |
Shibata, H | 1 |
Ohmori, N | 2 |
Nomura, K | 2 |
Ohmori, K | 1 |
Takano, K | 2 |
Obinata, D | 1 |
Yamaguchi, K | 1 |
Hirano, D | 1 |
Yoshida, T | 1 |
Soma, M | 1 |
Takahashi, S | 1 |
Naruse, M | 1 |
Naruse, K | 1 |
Demura, H | 2 |
Shizume, K | 1 |
Schteingart, DE | 1 |
Tsao, HS | 1 |
Bertagna, C | 1 |
Orth, DN | 2 |
Wetterberg, L | 1 |
Badawy, SZ | 1 |
Notman, DD | 1 |
Sunderlin, FS | 1 |
Springer, JM | 1 |
Streeten, DH | 1 |
Omar, MM | 1 |
Marshall, LD | 1 |
Gormley, MJ | 1 |
Hadden, DR | 2 |
Kennedy, TL | 1 |
Montgomery, DA | 1 |
Murnaghan, GA | 1 |
Sheridan, B | 2 |
Zgliczyński, S | 1 |
Laws, ER | 1 |
Abboud, CF | 1 |
Kern, EB | 1 |
Cassar, J | 1 |
Loizou, S | 1 |
Kelly, WF | 1 |
Mashiter, K | 1 |
Joplin, GF | 1 |
Freeman, DA | 1 |
Auzéby, A | 1 |
Bogdan, A | 1 |
Touitou, Y | 1 |
Suda, T | 1 |
Tozawa, F | 1 |
Dobashi, I | 1 |
Horiba, N | 1 |
Yamakado, M | 1 |
Yamada, M | 1 |
Cuneo, RC | 1 |
Lee, W | 1 |
Harper, J | 1 |
Mitchell, K | 1 |
Ward, G | 1 |
Atkinson, RL | 1 |
Salkield, I | 1 |
Cameron, DP | 1 |
Kainz, G | 1 |
Mammone, J | 1 |
Outwater, EK | 1 |
Courtney, CH | 1 |
McAllister, AS | 1 |
McCance, DR | 1 |
Leslie, H | 1 |
Atkinson, AB | 1 |
Shimizu, C | 1 |
Yamane, Y | 1 |
Ishizuka, T | 1 |
Kijima, H | 1 |
Takano, A | 1 |
Kubo, M | 1 |
Koike, T | 1 |
Besser, GM | 2 |
Jeffcoate, WJ | 1 |
Jaquet, P | 1 |
Grisoli, F | 1 |
Guibout, M | 1 |
Lissitzky, JC | 1 |
Carayon, P | 1 |
Schnall, AM | 1 |
Brodkey, JS | 1 |
Kaufman, B | 1 |
Pearson, OH | 1 |
Tecilazich, D | 1 |
Rosenwirth, D | 1 |
Tonini, G | 1 |
Mangiarotti-Marchi, MA | 1 |
Delaney, JP | 1 |
Solomkin, JS | 1 |
Jacobson, ME | 1 |
Doe, RP | 1 |
Turpin, G | 1 |
Heshmati, HM | 1 |
Roger, M | 1 |
Legrand, S | 1 |
Guillemant, S | 1 |
de Gennes, JL | 1 |
Liddle, GW | 2 |
Wiedemann, E | 1 |
Saito, T | 1 |
Linfoot, JA | 1 |
Li, CH | 1 |
Britton, S | 1 |
Thorén, M | 1 |
Sjoberg, HE | 1 |
Green, JR | 1 |
van't Hoff, W | 1 |
Carballeira, A | 2 |
Fishman, LM | 2 |
Jacobi, JD | 1 |
Kato, S | 1 |
Masunaga, R | 1 |
Kawabe, T | 1 |
Nagasaka, A | 1 |
Miyamoto, T | 1 |
Itoh, M | 1 |
Nakai, A | 1 |
Iwase, K | 1 |
Tsujimura, T | 1 |
Ohtani, S | 1 |
Noritake, M | 1 |
Morimoto, K | 1 |
Kosano, H | 1 |
Nemoto, Y | 1 |
Kugai, N | 1 |
Takao, M | 1 |
Murai, M | 1 |
Tamai, S | 1 |
Tanaka, K | 1 |
Nagata, N | 1 |
Verhelst, JA | 1 |
Trainer, PJ | 1 |
Howlett, TA | 2 |
Perry, L | 1 |
Rees, LH | 2 |
Grossman, AB | 1 |
Wass, JA | 1 |
Fuhrman, SA | 1 |
Huiras, CM | 1 |
Pehling, GB | 1 |
Caplan, RH | 1 |
Nakashima, H | 1 |
Hirata, Y | 1 |
Uchihashi, M | 1 |
Tomita, M | 1 |
Fujita, T | 1 |
Laurberg, P | 1 |
Møller, J | 1 |
Husager, L | 1 |
Weeke, J | 1 |
Watanobe, H | 1 |
Kawagishi, T | 1 |
Hirai, Y | 1 |
Sato, T | 1 |
Tsutsui, M | 1 |
Kamata, Y | 1 |
Takebe, K | 1 |
Carpenter, PC | 1 |
Girard, J | 1 |
Eberle, AN | 1 |
Baumann, JB | 1 |
Else, W | 1 |
Meikle, AW | 2 |
Jubiz, W | 1 |
Matsukura, S | 1 |
Harada, G | 1 |
West, CD | 2 |
Tyler, FH | 3 |
Smilo, RP | 2 |
Earll, JM | 1 |
Forsham, PH | 2 |
Buckell, M | 1 |
Strott, CA | 1 |
Nugent, CA | 1 |
Materazzi, F | 1 |
Tucci, JR | 1 |
Espiner, EA | 1 |
Jagger, PI | 2 |
Lauler, DP | 2 |
Thorn, GW | 1 |
Pasqualini, JR | 1 |
Beuve-Méry, P | 1 |
Meyer, P | 1 |
Sparks, LL | 1 |
Pavlatos, FC | 1 |
Bethge, H | 1 |
Bayer, JM | 1 |
Winkelmann, W | 1 |
Pennington, LF | 1 |
Kreisberg, RA | 1 |
Hershman, JM | 1 |
Weiss, ER | 1 |
Rayyis, SS | 1 |
Nelson, DH | 1 |
Bethune, JE | 1 |
Crystal, RG | 1 |
Rose, LI | 1 |
Bricaire, H | 1 |
Luton, JP | 1 |
Yuji, S | 1 |
Nakajima, T | 1 |
Watanabe, A | 1 |
Yamada, S | 1 |
Uozumi, T | 1 |
Mori, S | 1 |
Watanabe, M | 1 |
Takimoto, N | 1 |
Mogami, H | 1 |
Lagerquist, LG | 1 |
Cheng, SC | 1 |
Matthews, JI | 1 |
Fariss, BL | 1 |
Chertow, BS | 1 |
Howard, WB | 1 |
Jones, JE | 1 |
Graham, NA | 1 |
Seal, US | 1 |
Tada, T | 1 |
Sprunt, JG | 1 |
Hannah, DM | 1 |
Loridan, L | 1 |
Senior, B | 1 |
7 reviews available for metyrapone and Adenoma, Basal Cell
Article | Year |
---|---|
Rationale for treatment and therapeutic options in Cushing's disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenalectomy; Choice Behavior; Combined Modality Therapy | 2009 |
New prospects for drug treatment in Cushing disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trial | 2012 |
[Corticosterone-producing adrenal tumor].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Corticosterone; Diagnosis, Differential; Humans; Hy | 2006 |
The relationship between the pineal gland and the pituitary--adrenal axis in health, endocrine and psychiatric conditions.
Topics: Adenoma; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Circadian Rhythm; Cushing Syndr | 1983 |
Appropriate laboratory testing in the screening and work-up of Cushing's syndrome.
Topics: Adenoma; Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethaso | 1988 |
Is it possible to diagnose pituitary-dependent Cushing's disease?
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hor | 1985 |
Cushing's syndrome: update of diagnosis and management.
Topics: Adenoma; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushin | 1986 |
2 trials available for metyrapone and Adenoma, Basal Cell
Article | Year |
---|---|
Effect of estrogen on the metabolism of metyrapone and release of ACTH.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Chl | 1970 |
Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gla | 1969 |
77 other studies available for metyrapone and Adenoma, Basal Cell
Article | Year |
---|---|
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Coronavirus Infections; | 2020 |
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; C | 2021 |
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectom | 2017 |
[Indications and future perspectives in the pharmacological treatment of hypercortisolism].
Topics: Adenoma; Cushing Syndrome; Humans; Hydrocortisone; Italy; Ketoconazole; Metyrapone; Pituitary Neopla | 2016 |
Type 2 diabetes identified in pregnancy secondary to Cushing's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Cushing Syndrome; Diabetes Mellitus, Type 2 | 2011 |
The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas.
Topics: Adenoma; Adolescent; Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Corticotropin-Releasing | 2012 |
[Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenal Insufficiency; Adrenocorticotropic Ho | 2013 |
Cushing's syndrome during pregnancy: curative adrenalectomy at 31 weeks gestation.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Cushing Syndrome; Female; Gestational A | 2002 |
ASSESSMENT OF PITUITARY ACTH SECRETORY CAPACITY WITH METOPIRONE: 1. INTERPRETATION.
Topics: Acromegaly; Adenoma; Adenoma, Acidophil; Adenoma, Chromophobe; Adrenal Cortex Hormones; Adrenocortic | 1963 |
ASSESSMENT OF PITUITARY ACTH SECRETORY CAPACITY WITH METOPIRONE: II. COMPARISON WITH OTHER TESTS.
Topics: Acromegaly; Adenoma; Adenoma, Chromophobe; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Art | 1963 |
[SOME ASPECTS OF ENDOCRINE PROBLEMS AFTER EXCISION OF CHROMOPHOBE ADENOMAS].
Topics: Adenoma; Adenoma, Chromophobe; Adrenocorticotropic Hormone; Ketones; Metyrapone; Mineralocorticoid R | 1964 |
METYRAPONE AND PYROGEN IN THE ASSESSMENT OF PITUITARY-ADRENAL FUNCTION AFTER REMOVAL OF PITUITARY ADENOMA.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenocorticotropic Hormone; Blood; Hypopituitarism; Ketones; Me | 1964 |
MULTIPLE BRONCHIAL ADENOMAS, CUSHING'S SYNDROME AND HYPOKALEMIC ALKALOSIS. REPORT OF A CASE.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Alk | 1964 |
[A SURGICALLY TREATED CASE OF CONN'S SYNDROME. CLINICAL, HISTOLOGICAL AND BIOCHEMICAL FINDINGS].
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Alkalosis; Humans; Hyperal | 1964 |
EFFECTS OF ADMINISTRATION OF METOPIRON AND OF DELIVERY ON HUMAN PLASMA CORTICOTROPHIN.
Topics: Adenoma; Adenoma, Chromophobe; Adrenocorticotropic Hormone; Blood; Delivery, Obstetric; Female; Huma | 1965 |
CLINICAL ASSESSMENT OF THE PERORAL METOPIRONE TEST.
Topics: Adenoma; Adenoma, Chromophobe; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndrome; Diabete | 1965 |
Periodic secretion of adrenocorticotropin in a patient with Cushing's disease manifested during pregnancy.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Female; Humans; Hydroc | 2005 |
Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cushing Syndrome; Enzyme Inhibitors; Female; | 2006 |
Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenal Glands; Adrenocorticotropic Hormone; Aged; Antime | 2007 |
Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Depressive Disorder; Female; Humans; Metyrapone; Mi | 2008 |
In vivo evidence of cortisol secretion by aldosterone-producing adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Metyr | 1984 |
Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Fema | 1980 |
Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978).
Topics: Adenoma; Adolescent; Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenocorticotropic Ho | 1981 |
Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Infertility, Female; | 1982 |
Cushing's syndrome in pregnancy--treatment with metyrapone.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Female; Humans; Metyrapone; Pregnancy; Pr | 1982 |
[Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy].
Topics: Adenoma; Adolescent; Adult; Cushing Syndrome; Female; Humans; Male; Metyrapone; Middle Aged; Pituita | 1982 |
Perioperative management of patients with pituitary microadenoma.
Topics: Adenoma; Female; Humans; Hypopituitarism; Male; Metyrapone; Microsurgery; Pituitary Neoplasms; Posto | 1980 |
Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Carcinoma; | 1980 |
Adrenal carcinoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aminoglutethimide; Carcinoma; Cushing Syndrome; Dia | 1994 |
An alternate pathway to androstenedione synthesis by human adrenals: evidence of a balance in 11 beta-hydroxylase and 17,20-lyase activities leading to androstenedione.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult | 1995 |
Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Arginine | 1993 |
Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Cortodoxone; Cushin | 1997 |
Change in the composition of adrenal nodules after therapy as revealed by opposed-phase MR imaging.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aged; Female; Humans; Magnetic Resonance Imaging; | 1997 |
The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cortodoxone; Female; Follow-Up Studies; Humans; H | 2000 |
Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenocorticotropic Hormone; Atropine; Choline; | 2001 |
Endocrine and metabolic diseases. Adrenal diseases.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Insuffici | 1976 |
Prolactin secreting tumors. Endocrine status before and after surgery in 33 women.
Topics: Adenoma; Arginine; Female; Follicular Phase; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; | 1978 |
Pituitary function after removal of pituitary microadenomas in Cushing's disease.
Topics: 17-Ketosteroids; Adenoma; Adult; Cushing Syndrome; Follicle Stimulating Hormone; Humans; Hydrocortis | 1978 |
[Auxological problems in a case of virilizing adenoma of the adrenal gland].
Topics: 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Child; Child, Preschool; Dexamethasone; Growth Di | 1977 |
Surgical management of Cushing's syndrome.
Topics: Adenoma; Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocorticotropic Ho | 1978 |
[Adrenocortical function in hyperprolactinemia. The study of glucocorticoids, mineralocorticoids and androgens in chronic and acute hyperprolactinemias (author's transl)].
Topics: Acute Disease; Adenoma; Adrenal Cortex; Adrenocorticotropic Hormone; Androgens; Chronic Disease; Fem | 1979 |
Cushing's syndrome.
Topics: Adenoma; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Humans; Metyrapone; Pitui | 1977 |
Specific radioimmunoassay of human beta-endorphin in unextracted plasma.
Topics: Adenoma; Adrenal Gland Neoplasms; Carcinoma, Bronchogenic; Cushing Syndrome; Dexamethasone; Endorphi | 1979 |
The immunological hazard of Cushing's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Cryptococcosis; Cushing Syndrome; Female; Fluorouracil; Hum | 1975 |
Cushing's syndrome with fluctuation due to adrenal adenoma.
Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Circadian Rh | 1975 |
Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Glands; Adrenoco | 1976 |
Cushing's syndrome induced by hypersecretion of cortisol from only one of bilateral adrenocortical tumors.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adult; Cosyntropin; Cushing Syndrome; De | 1992 |
A case of asymptomatic cortisol producing adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Cushing Syndrome; Dexamethasone; Humans; Hydrocortisone; Hypothala | 1992 |
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; | 1991 |
Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Insufficiency; Adrenalectomy; Dex | 1989 |
Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Animals; beta-Endorphin; Bromocriptine; Corticotropin-R | 1985 |
Evaluation of pituitary-adrenal function after pituitary surgery.
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cortodoxone; Cranio | 1985 |
Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Circadian Rhythm; Cush | 1985 |
Plasma ACTH in diagnosis and control of adrenal disorders.
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adre | 1986 |
Pituitary-adrenal function tests in patients with untreated pituitary tumours.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cerebral Ventriculography; Female; Humans; Hydroc | 1968 |
Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfu | 1967 |
Endocrine function following treatment of pituitary adenoma.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenocorticotropic Hormone; Adult; Basal Metab | 1967 |
Cushing's syndrome caused by bronchial adenomas.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Biological Assay; Bronchial Neoplasms; C | 1968 |
[Reichstein's S substance in humans].
Topics: Adenocarcinoma; Adenoma; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; A | 1966 |
Vasopressin in the evaluation of pituitary-adrenal function.
Topics: Acromegaly; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Anorex | 1968 |
[Production and excretion of corticosteroids in primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Hormones; Angiotensin II; Carbon Isotopes; Dexamethasone; Humans; Hyperaldos | 1968 |
Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone | 1969 |
Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Cus | 1970 |
Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Ang | 1969 |
Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Horm | 1970 |
[Poly-micro-adenomatosis in Cushing's syndrome].
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndr | 1970 |
[Radioimmunoassay of ACTH].
Topics: 17-Hydroxycorticosteroids; Addison Disease; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Ho | 1971 |
Results of treatment in 108 patients with Cushing's syndrome.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Age | 1971 |
[Urinary 6beta-hydroxycortisol. II. Urinary 6beta-hydroxycortisol in different diseases and after administration of drugs].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Carcinoma; Cushing Syndrome; F | 1973 |
[Endocrinological evaluation of sellar and suprasellar tumor cases --the first report-- on preoperative pituitary function (author's transl)].
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Brain Neoplasms; Child; Chordoma; Craniopha | 1974 |
Cushing's disease with cure by resection of a pituitary adenoma. Evidence against a primary hypothalamic defect.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cushing Syndrome; Depression, Chemica | 1974 |
Metabolism of (4-14C) cholesterol by human adrenal glands in vitro and its inhibition by metyrapone.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; | 1974 |
Adrenal adenoma with variable response to dexamethasone suppression and metyrapone stimulation.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfun | 1972 |
Excretion of urinary free amino acids in Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Amino | 1969 |
[Clinical studies on urinary 17-ketogenic steroid fractions. 3. SU-4885 test in normal subjects and the patients with various endocrine disorders].
Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma; Adolescent; Adrenal Cortex Hormones; Adrenal Gland N | 1968 |
A comparison of of the potency of some 11beta-hydroxylase inhibitors using rat and human adrenal tissue.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Glands; Animals; Carbon Isotopes; | 1968 |
Cushing's syndrome in infancy.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Abnormalities, Multiple; Adenoma; Adrenal Gland Neoplasm | 1969 |